Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Brain Research|July 7, 2000
Reduced nicotinic receptor-mediated antinociception following in vivo antisense knock-down in ratR S Bitner, A L Nikkel, P Curzon, et al.
European Journal of Pharmacology|June 23, 1995
Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptorsM W Decker, D J Anderson, J D Brioni, et al.
Alzheimer Disease and Associated Disorders|January 1, 1995
Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective propertiesS P Arneric, J P Sullivan, M W Decker, et al.
Proceedings of the Western Pharmacology Society|January 1, 1995
Cholinergic channel activators: novel opportunities for the treatment of CNS disordersJ P Sullivan, M W Decker, D Donnelly-Roberts, et al.
European Journal of Pharmacology|June 9, 1998
Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in miceM W Decker, A W Bannon, M J Buckley, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptorsJ P Sullivan, M W Decker, J D Brioni, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterizationM W Decker, J D Brioni, J P Sullivan, et al.
Science (New York, N.Y.)|January 24, 1998
Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptorsA W Bannon, M W Decker, M W Holladay, et al.
European Journal of Pain (London, England)|February 17, 2012
Assessing carrageenan-induced locomotor activity impairment in rats: comparison with evoked endpoint of acute inflammatory painC Z Zhu, C D Mills, G C Hsieh, et al.
British Journal of Pharmacology|April 18, 2009
Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative painC Z Zhu, J P Mikusa, Y Fan, et al.
Pageof 7